Reid Huber

Currently holds a position at Bellicum Pharmaceuticals Inc

3.0

3.0

Position	Company	Period
Independent Director	Bellicum Pharmaceuticals Inc	Oct. 1, 2014 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-09-15	2025-09-12	Rapport Therapeutics Inc (RAPP)	B Purchase	30,133 +46.3% 445.17 US$2,892,189	30,133 +46.3%	445.17	US$2,892,189
2016-11-10	2016-11-09	Incyte Corp (INCY)	PlS Planned sale	81,106 -40.1% 60.83 US$4,944,519	81,106 -40.1%	60.83	US$4,944,519
2016-08-02	2016-08-02	Incyte Corp (INCY)	PlS Planned sale	36,909 -7.7% 240.64 US$1,220,154	36,909 -7.7%	240.64	US$1,220,154